Abstract
With emerging cases of adrenal suppression being reported in pediatric patients, finding appropriate steroid sparing agents is of clinical importance. Tiotropium bromide (TB), a long-acting anticholinergic, has recently been investigated in adults as a steroid-sparing agent in asthma step-up therapy. We report the first case of tiotropium bromide (TB) used as a step-up steroid sparing agent in an adolescent with adrenal suppression secondary to inhaled mometasone furoate (MF).
Highlights
With emerging cases of adrenal suppression being reported in pediatric patients, finding appropriate steroid sparing agents is of clinical importance
We report the first case of tiotropium bromide (TB) used as a step-up steroid sparing agent in an adolescent with adrenal suppression secondary to inhaled mometasone furoate (MF)
Case description A sixteen-year-old female with asthma and allergic rhinitis treated MF/formoterol fumarate 800/ 20 mcg per day in addition to intranasal MF presented with increasing fatigue, weight loss, nausea and striae
Summary
With emerging cases of adrenal suppression being reported in pediatric patients, finding appropriate steroid sparing agents is of clinical importance. Use of tiotropium bromide in an adolescent with adrenal suppression secondary to inhaled mometasone furoate From Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2014 Ottawa, ON, Canada. Introduction With emerging cases of adrenal suppression being reported in pediatric patients, finding appropriate steroid sparing agents is of clinical importance.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
